Abstract:AIM To investigate the expression and clinical significance of cathepsin D and chromogranin A in human primary hepatocellular carcinoma (HCC). METHODS Double immunofluorescence staining techniques combined with laser confocal scanning microscopy were used to study cathepsin D and chromogranin A expression in 85 HCC patients. RESULTS Cathepsin D was expressed in normal hepatocytes, while in HCC the staining showed regional variation and the fraction of strongly stained cells increased as the tumors became less differentiated and usually clinically more malignant. Cells which showed strong positivity for cathepsin D were present in 71/85(83 5%) cases. Strong expression of cathepsin D in cancer cells was related to histopathological features. They were more common in grade 3-4 (26/28, 92 9%) and grade 2 (46/53, 86 8%) tumors than in grade l tumors (1/4, 25 0%) ( P 0 01). There was no significant correlation between the age and cathepsin D expression. In cases with positive cathepsin D reaction the mean age was 52 1 ± 2 8 years (range 32 -68 years) and in the group with negative reaction, the mean age was 51 2 years ±4 5 years (range 28 years-71 years). No obvious relationship was observed between expression of CgA in cancer cells and the histopathological features. The CgA positive rate was 75 0%(3/4) in grade 1, 71 7%(38/53) in grade 2 tumors, and 71 4%(20/28) in grade 3-4 ( P 0 05). The coexpression of CgA and cathepsin D was found by double labeled immunofluorescence staining techniques. The results suggested that the processing of cathepsin D was disturbed in HCC cells and accumulated in the cells. Cathepsin D had proteolytic activity and autocrine mitogenic effect, both of which suggest some function in invasion. These findings demonstrated the expression of cathepsin D in HCC has some prognostic value. CONCLUSION Chromogranin A and cathepsin D are expressed in a high proportion of HCC and the existence of cathepsin D in HCC might be related to processing of CgA. This is clearly a subject worthing further studies because of its potential in clinical applications.

Cathepsin H: molecular characteristics and clues to function and mechanism

Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways

Cathepsin K: a therapeutic target for bone diseases.

Cathepsin B As a Target in Cancer Therapy and Imaging

Significance of Cathepsin D and Chromogranin A Expression in Human Primary Hepatocellular Carcinomas

Relationship between Cathepsin L and Neurodegenerative Diseases

Cathepsin C in health and disease: from structural insights to therapeutic prospects

Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies

Cathepsin B of Cynoglossus Semilaevis: Identification, Expression, and Activity Analysis

Cysteine Cathepsins: From Diagnosis to Targeted Therapy of Cancer

Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment

Cysteine Cathepsins in Tumor-Associated Immune Cells

Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma

Beyond basic research: the contribution of cathepsin B to cancer development, diagnosis and therapy

Cathepsin B: The dawn of tumor therapy

Identification of Cathepsin B As a Novel Target of Hypoxia-Inducible Factor-1-alpha in HepG2 Cells.

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Cathepsin L Activity Controls Adipogenesis and Glucose Tolerance.

Structural basis for the recognition and cleavage of histone H3 by cathepsin L

Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases

Cathepsin C inhibition as a potential treatment strategy in cancer